CALLI COLLINS: Open Payments
NPI 1386393304 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,505 in 51 payments from 12 companies in 2025. Trend: 2023 $718 · 2024 $1,109 · 2025 $1,505
Food & beverage: $1,505
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $314 |
| Gilead Sciences, Inc. | 9 | $306 |
| ViiV Healthcare Company | 12 | $260 |
| Amgen Inc. | 6 | $207 |
| PFIZER INC. | 6 | $137 |
| Antares Pharma, Inc. | 4 | $79 |
| Exact Sciences Corporation | 4 | $59 |
| Intra-Sana Laboratories | 2 | $38 |
| Astellas Pharma US Inc | 1 | $30 |
| Novo Nordisk Inc | 1 | $28 |
Products named: QULIPTA, APRETUDE, KRYSTEXXA, NURTEC ODT, Yeztugo, XYOSTED, The Cologuard Plus Collection Kit, RELTONE 200 MG.
Industry payments across NV — which companies pay providers there.
